Epidemiology and clinical outcomes of light‐chain amyloidosis in Sweden: A nationwide population‐based study
Mellqvist, Ulf‐Henrik, Cai, Qian, Hester, Laura L., Grövdal, Michael, Börsum, Jakob, Rahman, Iffat, Ammann, Eric M., Hansson, Markus
Published in European journal of haematology (01.11.2023)
Published in European journal of haematology (01.11.2023)
Get full text
Journal Article
Comprehensive mapping of the effects of azacitidine on DNA methylation, repressive/permissive histone marks and gene expression in primary cells from patients with MDS and MDS-related disease
Tobiasson, Magnus, Abdulkadir, Hani, Lennartsson, Andreas, Katayama, Shintaro, Marabita, Francesco, De Paepe, Ayla, Karimi, Mohsen, Krjutskov, Kaarel, Einarsdottir, Elisabet, Grövdal, Michael, Jansson, Monika, Ben Azenkoud, Asmaa, Corddedu, Lina, Lehmann, Sören, Ekwall, Karl, Kere, Juha, Hellström-Lindberg, Eva, Ungerstedt, Johanna
Published in Oncotarget (25.04.2017)
Published in Oncotarget (25.04.2017)
Get full text
Journal Article
Negative Effect of DNA Hypermethylation on the Outcome of Intensive Chemotherapy in Older Patients with High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia following Myelodysplastic Syndrome
GRÖVDAL, Michael, KHAN, Rasheed, OLSSON, Anna, WALLVIK, Jonas, MAGNUS TANGEN, Jon, OBERG, Gunnar, EIRIK JACOBSEN, Sten, HOKLAND, Peter, PORWIT, Anna, HELLSTRÖM-LINDBERG, Eva, AGGERHOLM, Anni, ANTUNOVIC, Petar, ASTERMARK, Jan, BERNELL, Per, ENGSTRÖM, Lena-Maria, KJELDSEN, Lars, LINDER, Olle, NILSSON, Lars
Published in Clinical cancer research (01.12.2007)
Published in Clinical cancer research (01.12.2007)
Get full text
Journal Article
Evaluation of Azacitidine in Transfusion-Dependent, Epo-Refractory Patients with Lower-Risk Myelodysplastic Syndrome
Tobiasson, Magnus, Brandefors, Lena, Dybedal, Ingunn, Garelius, Hege, Grövdal, Michael, Dufva, Inge Hoegh, Kjeldsen, Lars, Nilsson, Lars, Kittang, Astrid Olsnes, Porwit, Anna, Saft, Leonie, Holm, Mette Skov, Möllgård, Lars, Hellström-Lindberg, Eva
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
Different Incidence and Implications of DNA Hypermethylation in De Novo AML Compared to High-Risk MDS and AML Following MDS
Deneberg, Stefan, Grövdal, Michael, Jansson, Monika, Gaidzik, Verena I., Corbacioglu, Andrea, Nahi, Hareth, Bengtzen, Sofia, Döhner, Konstanze, Paul, Christer, Hellström-Lindberg, Eva, Lehmann, Sören
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article
Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndr–ome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy
Grövdal, Michael, Khan, Rasheed, Aggerholm, Anni, Antunovic, Petar, Astermark, Jan, Bernell, Per, Engström, Lena-Maria, Kjeldsen, Lars, Linder, Olle, Nilsson, Lars, Olsson, Anna, Wallvik, Jonas, Tangen, Jon Magnus, Öberg, Gunnar, Jacobsen, Sten Eirik, Porwit, Anna, Hokland, Peter, Hellström-Lindberg, Eva
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article
Maintenance Treatment with Azacytidine for Patients with High Risk Myelodysplastic Syndromes or Acute Myeloid Leukaemia in Complete Remission after Intensive Chemotherapy
Grövdal, Michael, Khan, Rasheed, Aggerholm, Anni, Antunovic, Petar, Astermark, Jan, Bernell, Per, Engström, Lena-Maria, Kjeldsen, Lars, Linder, Olle, Nilsson, Lars, Olsson, Anna, Wallvik, Jonas, Tangen, Jon Magnus, Öberg, Gunnar, Jacobsen, Sten Eirik, Hokland, Peter, Porwit, Anna, Hellström-Lindberg, Eva
Published in BLOOD (16.11.2007)
Published in BLOOD (16.11.2007)
Get full text
Journal Article
Conference Proceeding
Light-Chain Amyloidosis in Sweden (2011-2019): Incidence, Disease Burden, and Clinical Outcomes in Real-World Patients
Mellqvist, Ulf-Henrik, Cai, Qian, Hester, Laura L, Grövdal, Michael, Börsum, Jakob, Rahman, Iffat, Ammann, Eric M., Hansson, Markus
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Maintenance treatment with azacytidine for patients with high‐risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy
Grövdal, Michael, Karimi, Mohsen, Khan, Rasheed, Aggerholm, Anni, Antunovic, Petar, Astermark, Jan, Bernell, Per, Engström, Lena‐Maria, Kjeldsen, Lars, Linder, Olle, Nilsson, Lars, Olsson, Anna, Holm, Mette S., Tangen, Jon M., Wallvik, Jonas, Öberg, Gunnar, Hokland, Peter, Jacobsen, Sten E., Porwit, Anna, Hellström‐Lindberg, Eva
Published in British journal of haematology (01.08.2010)
Published in British journal of haematology (01.08.2010)
Get full text
Journal Article
Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy
Grovdal, Michael, Khan, Rasheed, Aggerholm, Anni, Antunovic, Petar, Astermark, Jan, Bernell, Per, Engstroem, Lena-Maria, Kjeldsen, Lars, Linder, Olle, Nilsson, Lars, Olsson, Anna, Wallvik, Jonas, Tangen, Jon Magnus, Oeberg, Gunnar, Jacobsen, Sten Eirik, Porwit, Anna, Hokland, Peter, Helistrom-Lindberg, Eva
Published in 50th Annual Meeting of the American- Society-of-Hematology,2008-12-06 - 2008-12-09 (2008)
Get full text
Published in 50th Annual Meeting of the American- Society-of-Hematology,2008-12-06 - 2008-12-09 (2008)
Conference Proceeding